1. (4R)4[4a-(2-Carboxyethyl)-3aa-hexahydro-7af8-methyl-5-oxoindan-fl-yl]valeric acid (II) could not be utilized by Arthrobacter simplex, even though the acid was one of the metabolites formed from cholic acid (I) by this organism. Therefore the further degradation of the acid (IT) by Corynebacterium equi was investigated to identify the intermediates involved in the cholic acid degradation. 2. The organism, cultured in a medium containing the acid (II) as the sole source of carbon, produced unexpected metabolites, the conjugates of this original acid (LI) with amino acids or their derivatives, although the yield was very low. These new metabolites were isolated and identified by chemical synthesis
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By SHOHEI HAYAKAWA, TAKASHI FUJIWARA and HARUKO KAKO* Shionogi Research Laboratory, Shionogi and Co. Ltd., Fukushima-ku, Osaka, 553 Japan (Received 22 March 1976) 1. (4R)4[4a-(2-Carboxyethyl)-3aa-hexahydro-7af8-methyl-5-oxoindan-fl-yl]valeric acid (II) could not be utilized by Arthrobacter simplex, even though the acid was one of the metabolites formed from cholic acid (I) by this organism. Therefore the further degradation of the acid (IT) by Corynebacterium equi was investigated to identify the intermediates involved in the cholic acid degradation. 2. The organism, cultured in a medium containing the acid (II) as the sole source of carbon, produced unexpected metabolites, the conjugates of this original acid (LI) with amino acids or their derivatives, although the yield was very low. These new metabolites were isolated and identified by chemical synthesis as the N-{(4R)-[4a-(2-carboxyethyl)-3aa-hexahydro-7aa-methyl-5-oxoindan-la-yl]-valeryl} derivatives of L-alanine, glutamic acid, O-acetylhomoserine and glutamine, i.e. compounds (lIIa), (IIIb), (IlIc) and (II1d) respectively. 3. The possibility that the bacterial synthetic reaction observed in the acid (II) metabolism with C. equi is analogous to peptide conjugation known in both animals and higher plants is discussed. A possible mechanism for this bacterial conjugation is also considered.
Our continued interest in the intermediates and reaction sequence involved in the degradation of 3a,7a,12a-trihydroxy-5,8-cholan-24-oic acid (cholic acid) (I) by micro-organisms has prompted us to search for further degradation products of (4R)-4-[4ca-(2-carboxyethyl)-3aa-hexahydro-7afl-methyl-5-oxoindan-l1i-yl]valeric acid (II), which was one ofthe degradation products formed from cholic acid (I) by Arthrobacter simplex (Hayakawa et al., 1969 ) (Scheme 1). As described in a previous paper, however, the oxodicarboxylic acid (II) could not be utilized by this organism (Hayakawa et al., 1976a) . As one of the approaches to this problem, therefore, we made a search for other micro-organisms that are able to utilize the acid (II), and found that Corynebacterium equi was able to achieve this degradation (cf. Hayakawa et al., 1976b) .
The present paper describes the isolation and identification of new metabolites formed from the acid (II) by C. equi; a preliminary note of this work has already appeared (Hayakawa et al., 1968) .
Results
Isolation of the metabolites and their structure assignments No growth of A. simplex occurred in both a medium containing the oxodicarboxylic acid (II) * N6e Tsuchikawa. Vol. 160 (1 g/l) as the sole source of carbon and the same medium supplemented with yeast extract (0.5 g/1). C. equi was also unable to grow in the former but grew well in the latter, and it very rapidly degraded the acid (II) without apparent accumulation of metabolites. However, C. equi pre-cultured in the latter was able to grow well even in the former, and rapidly degrade the acid (II), so that it was difficult to monitor the course of the degradation of the acid (II) and of the formation ofits metabolites by t.l.c. It was possible to accomplish the monitoring by increasing the concentration of the acid (II) in the former up to 3 g/l. Further, compared with this case, C. equi, precultured in a medium containing yeast extract (0. 5g/1) and (4R)-4-[3aa-hexahydro-5f8-hydroxy-4a-(3 -hydroxypropyl) -7a8-methylindan -,fl-yl]valeric acid (VI) (1 g/l) instead of the acid (II) as carbon sources, degraded both the acid (II) and its metabolites more slowly in this 0.3 % medium and afforded a better yield of the metabolites. However, if the incubation is continued until the acid (II) is completely consumed, once-formed metabolites were further degraded even under such conditions. Then the incubation was stopped when a small amount of the unaltered acid (II) was still present in the incubation mixture, and the mixture was immediately used for the isolation of metabolites.
(a) L-Alanine conjugate. This was isolated as crystals, its elementary analysis was consistent with C2,H33NO06 and non-aqueous titration gave a neutralization equivalent of 380 as dicarboxylic acids.
The i.r. spectrum showed the presence of both amide and carboxyl groups at 3460, 1617 and 1551 and approx. 3200, approx. 2500, 1740 and 1700cm-1 respectively. On being heated with 6M-HCl to hydrolyse the amide bond, the metabolite yielded the acid (II) and a ninhydrin-positive substance. The latter corresponded to alanine in the amino acid analyser. It was then converted into the corresponding N-2,4-dinitrophenyl derivative and isolated as crystals by the method of Sanger (1945) . Identity with an authentic sample ofN-2,4-dinitrophenyl-L-alanine was established by direct comparison. From these data, the structure of this metabolite was assigned as either N- A triplet at 3 4.13 (2H) p.p.m. in the n.m.r. spectrum could be assigned to two protons of an acetoxymethylene group attached to a particular methylene group in the ac-amino acid moiety; this was further supported by the presence of an O-acetyl group described above. An absorption at 1703ncm-' in the i.r. spectrum was assigned as the carbonyl group in the acid (II) moiety. Accordingly it was concluded that the a-amino acid moiety in this conjugate is 0-acetylhomoserine. Armstrong (1949) reported that homoserine was in equilibrium with its lactone form, 2-amino-4-hydroxybutyric acid lactone (ac-amino-y-butyrolactone); increasing amoUnts of the lactone are present in more strongly acidic solutions. It could therefore be conceivable that the major basic substance in the hydrolysate might be a-amino-y-butyrolactone and another minor component homoserine. That the sample, which was isolated from the first run and consisted of two components, was a mixture of the respective conjugates of the acid (II) with O-acetylhomoserine and a-amuno-y-butyrolactone Vol. 160 was established by direct comparison with the synthetic samples of these conjugates.
(d) L-Glutamine conjugate. The fourth metabolite was isolated as an amorphous powder containing minute quantities of impurities. On hydrolysis with 6M-HCI, it produced the acid (II) and approximately equal amounts of glutamic acid and ammonia. Thus the structure of this metabolite was assigned as a primary mono-amide derivative of either one of the six carboxyl groups in the two possible structures of the above glutamic acid conjugate. The i.r. and n.m.r. spectra of the corresponding dimethyl ester, which was purified by preparative t.l.c., were fully consistent with this assignment (see under 'Isolation of the metabolites' in the Experimental section). However, it was unknown from these data whether the metabolite was the conjugate of the acid (II) with glutamine itself until its partial synthesis was achieved.
Partial syntheses ofthe conjugates
Which isomer of the respective two possible structures for the L-alanine, glutamic acid and 0-acetylhomoserine conjugates was correct was ascertained by partial synthesis (Scheme 2).
L-Alanine conjugate (lIIa). We at first synthesized one of the two possible isomers of the -alanine conjugate, the hexahydroindanylvaleryl-L-alanine (lIa), since we have kept a convenient starting material, (4R)-4- (2,3,4,6,6a,f,7,8,9,9aa,9bfl - (Hayakawa et al., 1976b) , in which the propionic acid side chain of the oxodicarboxylic acid (II) was already protected against a coupling reaction with amino acids as an enaminolactam form. The enaminolactam acid (IV) was converted into the corresponding L-alanine conjugate (V) by the usual coupling method of mixed carbonic-carboxylic anhydrides with amino acids, which had been applied for the partial syntheses of conjugated bile acids by Norman (1955) . On partial hydrolysis with dilute HCI in dioxan, the conjugate (V) afforded the hexahydroindanylvaleryl-L-alanine (Illa). Fortunately, the synthetic sample was identical in all respects (t.l.c., m.p., mixed m.p., [a]D and i.r.) with the L-alanine conjugate isolated from growing cultures. The result also excluded another possible structure for this metabolite, the hexahydroindanylpropionyl-L-alanine.
The above synthetic method gave trouble in the isolation of the final product. It also appeared that this inethod would be unsatisfactory for the syntheses ofthe 0-acetylhomoserine and glutamine conjugates, which are labile to hot dilute HCI. While our study was in progress, we came across a publication on the syntheses of N-acylamino acids using N-hydroxysuccinimide esters by Lapidot et aL (1967) , The method was used for our synthetic work. Since 6 7~~~~~( n -( was easily available to us (Hayakawa et al., 1976a) , the 58-dihydroxy acid was converted into its Nhydroxysuccinimideester (VII) and then oxidized with Jones reagent (Curtis et al., 1953) to yield the halfester (VIII) of the acid (II) with N-hydroxysuccinimide. The half-ester was coupled with L-alanine to afford the corresponding L-alanine conjugate (MIIa).
L-Glutamic acid conjugate (IIIb). Exactly as described above for the L-alanine conjugate (Ila), L-glutamic acid was condensed with the half-ester (VIII) to afford the crystalline disodium salt of the corresponding L-glutamic acid conjugate (IIIb). The synthetic sample gave no satisfactory analytical values, but the behaviour on t.l.c. was identical with that of the glutamic acid conjugate obtained from growing cultures. Since the isolated sample had been obtained as its monosodium salt, both the i.r. spectra of these samples were not identical, of course, with each other. However, the corresponding trimethyl ester, prepared from the disodium salt, was identical in all respects (t.l.c., i.r. and n.m.r.) with the trimethyl ester of the isolated sample. O-Acetyl-L-homoserine conjugate (IlIc). The crystalline disodium salt of L-homoserine conjugate (IX), prepared by coupling the half-ester (VIII) with L-homoserine, was treated by the O-acetylation method for hydroxyamino acids reported by Sakami &Toennies (1942) and yielded a mixture of products, which mainly consisted of two components. After esterification, each component was isolated as methyl esters. The major one was identified as the methyl ester of N- L-Glutamine conjugate (IIId). As the first object of partial synthesis, the structure Na-
chosen from the six possible formulations assigned to the fourth metabolite for the ease of preparation. The condensation ofthe half-ester (VIII) with L-glutamine afforded the corresponding L-glutamine conjugate (IIId) as an amorphous powder. Fortunately, the behaviour on t.l.c. and the i.r. spectrum were identical with those of the fourth metabolite obtained from growing cultures. Further, there was no difference in the behaviour on t.l.c. and the i.r. and n.m.r. spectra between the respective dimethyl esters of both the synthetic and isolated samples.
Experimental General
Methods for incubation, centrifugation and physical measurements were as described by Hayakawa et al. (1969) . Unless otherwise stated, optical rotations and i.r.-absorption spectra were determined in chloroform solution.
Chromatography
Details of adsorption column chromatography were given by Hayakawa et al. (1969) , except where otherwise indicated. Methods for t.l.c. and reversedphase partition chromatography were as described in the preceding paper (Hayakawa et al., 1976b) , except that cyclohexane/ethyl acetate/acetic acid (5:5:1, by vol.) was used as a developing solvent system for both analytical and preparative t.l.c. and that both the solvent systems Fl and F2 were used for partition Vol. 160 chromatography [for a ratio of solvents, see Sjovall (1964) 
Media
A synthetic medium was prepared by addition of the'disodium salt ofthe oxodicarboxylic acid (II) (1 or 3g) or the sodium salt of the 511-dihydroxy acid (VI) (1 g) to a mineral solution (1 litre) which contained (g/l): (NH4)2SO4, 2; KH2PO4, 1; MgS04,7H20, 0.5; KCI, 0.5; FeSO4,7H20, 0.01 [for compounds (II) and (VI), see under 'Other materials' below]. In some cases the media were supplemented with yeast extract (0.5g/l; Difco Laboratories, Detroit, MI, U.S.A.) to obtain a better growth. All the media were adjusted to pH7A4 with 1M-NaOH, and the 100ml amounts of medium in a 500ml shake-flask were sterilized by autoclaving (1 kg/cm2 for 20min).
Other materials (Hayakawa et al., 1969) (Hayakawa et al., 1976a ) and (4R)-4- (2,3,4,6,6af8,7,8,9 ,9aax,9bfi-decahydro-6af8-methyl-3-oxo-1H-cyclopentaffquinolin -7fl-yl)valeric acid (IV) (Hayakawa et al., 1976b) 3350, 3088, approx. 2400 3350, 3088, approx. -2800 3350, 3088, approx. , 1720 3350, 3088, approx. , 1680 3350, 3088, approx. , 1624 3350, 3088, approx. , 1590 3350, 3088, approx. , 1524 3350, 3088, approx. , 1505 3350, 3088, approx. , 1460 3350, 3088, approx. , 1414 3350, 3088, approx. and 1361 H, 3.6; N, 16.5. Calc. for CqHqN306: C, 42.4; H, 3.6 ; N, 16.5). Rao & Sober (1954) Incubation ofthe oxodicarboxylic acid(II) with C. equi
The 2-day-old culture broth (2ml) of C. equi, precultured in a medium containing both the 5f9-dihydroxy acid (VI) (1 g/l) and yeast extract (0.5 g/1) as carbon sources, was transferred to the shake-flask containing an incubation medium (100ml) that contained the oxodicarboxylic acid (II) (3 g/l) as the sole source of carbon. The inoculated flasks were incubated, and the course of the degradation of the acid (TI) was monitored by t.l.c. as described for the degradation of cholic acid by A. simplex (Hayakawa et al., 1969) . When the result of t.l.c. indicated both the new appearance of the more polar products than the acid (U) and the residual presence of a small amount of the unaltered acid (II), the incubation was stopped. The incubation was usually continued for approx. 40-50h.
Extraction andfractionation ofthe metabolites The incubation mixture, which was judged by the result oft.l.c., was centrifuged to remove the cells. The cell-free supernatant (approx. 20 litres), resultingfrom the consumption of the acid (II) (60g), was acidified with dilute HCI to pH approx. 4 and extracted three times with 6-litre portions of chloroform. The extract was washed with water, dried over anhydrous Na2SQ4 and then evaporated in vacuo to yield a crystalline residue (6.63 g). The washings were combined with the aqueous layer. On recrystallization from acetone, the residue recovered the unaltered acid (II) (4.53 g).
The mother liquor, after evaporation of the solvent, was subjected to chromatography on silicic acid (85 g). Elution with ether yielded also the acid (II) (1.6g).
The aqueous layer, after removal ofthe chloroformsoluble materials, was neutralized with 5% (w/v) NaHCO3 to pH approx. 7.5 and concentrated in vacuo to approx. 1 litre. 13;no. 14andno. 15;no. 16andno. 17;no. 18 and no. 19; no. 20 and no. 21; no. 22 and no. 23; and no. 24 
Isolation ofthe metabolites
Pool A was a complex mixture of products, which mainly consisted of less polar products than the oxodicarboxylic acid (II). Attempts to isolate any components in a pure form were unsuccessful, except for the recovery of the acid (II) (63mg, m.p. 165-16rC). Both pools B and C mainly consisted of the products that move more slowly on t.l.c. than the acid (II) but faster than the L-alanine conjugate, and they were not further treated.
(a) Isolation of the L-alanine conjugate (lIIa) from pool D. The pool (482mg), which mainly consisted of a metabolite having RF 0.21 on t.l.c., was dissolved in water (approx. 5 ml) with the aid ofa minim.al amount of 5 % (w/v) NaHCO3. Ether (approx. 5ml) was then layered over the solution and thoroughly mixed. The mixture was acidified with dilute HCI to cause incipient cloudiness and kept overnight in a refrigerator. The prismatic crystals (38mg) of N- (Hostalen S, 230g ; solvent system FI) and part of each fraction (10ml) was tested by t.l.c. Fractions that are similar to each other in compositions on t.l.c. were pooled, and evaporation of the solvents in vacuo left the following pattern: pool E-1 (from fraction no. 1 to no. 9), no detectable amount of materials; pool E-2 (from fraction no. 10 to no. 13), 66mg; pool E-3 (from fraction no. 14 to no. 21), 184mg; pool E-4 (from fraction no. 22 to no. 36), 166mg; pool E-5 (from fraction no. 37 to no. 42), 39mg; pool E-6 (from fraction no. 43 to no. 65), 233 mg; and pool E-7 (from fraction no. 66 to no. 93), 62mg. After the elution of fraction no. 93, the column was further eluted with methanol (approx. 200ml), and evaporation of the methanol afforded a residue (pool E-8, 326mg) .
Pool E-2 (66mg), which mainly consisted of a metabolite having RF 0.14 on t.l.c., was treated by the method that was described above for the crystallization of the L-alanine conjugate (Illa) and afforded only a very small amount of crystals. However, another crystalline product (68mg), which was similar in behaviour on t.l.c. to the crystals obtained from the first run, were obtained from the second run.
In this run, the acid (II) (120g) was incubated with C. equi and the resulting incubation mixture was treated in a manner similar to that described above for the first run. The crystals obtained from the second run, on further recrystallization from methanol/water, Pool E-3 mainly consisted of both compounds (HIla) and (IIIb), and pool E-5 contained mainly both compound (IIIa) and the O-acetylhomoserine conjugate described below, as indicated by t.l.c. These were not subjected to further purification. Pool E4 was treated by the above crystallization method of compound (Illa) and yielded compound (Illa) (28mg). Pool E-6 (233mg) was further submitted to reversed-phase partition chromatography (Hostalen S, 80g; solvent system F2), and the 4mn1 amounts of each fraction were collected, yielding 48 fractions. Fractions no. 34 and no. 35 which gave a practically single spot (RF 0.19) on t.l.c., were combined, and evaporation of the solvents left an amorphous powder (41 mg). It moved as two spots (Rp 0.33 and 0.40) on t.l.c. after methylation with ethereal diazomethane. However, another sample (75mg), which ran as one spot ont.l.c. in both the free acid (RF 0.19) and methyl ester (RF 0.40) forms, was obtained from the second run, which was described above in the isolation of compound (UlIb). The latter sample, on esterification with ethereal diazomethane, yielded
homoserine (IIIc)dimethylesterasan oil, which showed i.r. bands at 3430 (NH), 1737 (C=O of ester and acetate), 1703 (C_O) and 1676 and 1502 (CONH) cm-' and n.m.r. absorptions at approx. 0.93 (3H; superimposable doublet; Me in the side chain), 0.99 (3H; singlet; 7afl-Me), 2.03 (3H; singlet; OAc), 3.65 (3H; singlet; CO2Me), 3.76 (3H; singlet; CO2Me), 4.13 (2H; triplet; CH2OAc in the O-acetylhomoserine moiety), 4.67 (1H; multiplet; CH in the O-acetylhomoserine moiety) and 6.11 (1H; broad peak; CONH) p.p.m.
The above sample isolated from the first run was esterified with ethereal diazomethane. The behaviour on t.l.c. was identical with that of a mixture of the respective methyl esters of the above O-acetylhomoserine conjugate (IlIc) and the a-amino-y-butyro-lactone conjugate (X), which was isolated as a byproduct in the partial synthesis of compound (Mc) as described below.
Pools E-7 and E-8 were not further treated, since they were an intractable mixture of products, which consisted of less polar products than compound (HIIa). Pool F mainly comprised compounds (ma), (IlIb) (IlIa) . A solution of the conjugate (59mg) in 6M-HCI (Sml) was heated in a sealed evacuated glass tube at 100-1050C for 16h. The brownish prisms (40mg) that were precipitated on cooling were filtered, washed with water and then dried. The mother liquor was used for the analysis of amino acids. The crystals were decolorized with activated charcoal powder in approx. 90% (v/v) methanol and then recrystallized from acetone to afford the oxodicarboxylic acid (I) as prisms (18mg) A small sample of the mother liquor was evaporated in vacuo to dryness, redissolved in a small volume of water and then subjected to analysis in the amino acid analyser. The sample yielded one peak at the elution volume 107ml that was identical with that of L-alanine (a buffer solution of pH3.25, a 50cm column and an elution rate of30ml/h). The remaining mother liquor was thoroughly extracted with ether. Evaporation of the ether gave the crude acid (II) (7mg), The aqueous layer was evaporated in vacuo to yield a crystalline residue. The residue was redissolved in water (0.75ml) containing NaHCO3 (60mg), and a solution of 1-fluoro-2,4-dinitrobenzene (60mg) in ethanol (1.5ml) was added. The mixture was stirred for 2h at room temperature and then extracted with ether to remove the excess of 1-fluoro-2,4-dinitrobenzene. The yellowish crystals that were precipitated on acidification of the aqueous layer with dilute HCl were filtered, washed with water and then dried. Recrystallization from methanol/water afforded N-2,4-dinitrophenyl-L-alanine (17mg) Isolation and characterization ofcomponents of the conjugates (IlIb), (Illc) and (IId). Although these conjugates could not be isolated as analytically pure forms, each sample (approx. 5mg), which behaved as a practically single spot on t.l.c., was treated with 6M-HCI (approx. 1 mi) without further purification, as described above in the hydrolysis of compound (Illa). A crude sample of the conjugate (IIc) isolated from the first run was also subjected to this hydrolysis. The acid (II) was commonly extracted with ether from all four hydrolysates and its identity with an authentic sample was established by mixed m.p. and by t.l.c.
The respective aqueous mother liquors, after each removal of compound (II), were separately evaporated in vacuo to dryness and submitted to analysis in the amino acid analyser. The hydrolysate of compound (ITlb) yielded one peak at the elution volume 70ml, which is identical with that of L-glutamic acid (a buffer solution of pH 3.25, a 50cm column and an elution rate of 40ml/h). Both the hydrolysates of two samples of compound (IMIc) isolated from both the first and second runs yielded the following same peaks: two peaks at the elution volume 67ml (a buffer solution of pH3.25, a 50cm column and an elution rate of 30ml/h) and at 92ml (a buffer solution of pH 5.28, a 15cm column and an elution rate of 30ml/ h). The former was a minor peak and the latter a major one. These peaks were identical in elution volume with those of L-homoserine and a-amino-ybutyrolactone respectively. Partial syntheses ofthe conjugates L-Alanine conjugate (llIa). (a) From the enaminolactam acid (IV). To a solution of the acid (2.433 g) in anhydrous dioxan (150ml) containing tri-n-butylamine (2ml) was added ethyl chloroformate (0.91 ml), with cooling to approx. 10°C. A solution of L-alanine (784mg) in IM-NaOH (8.8ml) was added immediately to the mixture and rapidly stirred at room temperature for 4h. Evaporation of the solvents left a syrup, which was suspended in dilute HCI (50ml) and extracted with ethyl acetate. The extract was washed with water, dried over anhydrous Na2SO4 and evaporated in vacuo to afford a residue (2.958g). The residue was treated by the crystallization method described above in the isolation of compound (Illa) from pool D, and yielded a crystalline powder (2.054g). Repeated recrystallization from methanol/ ethyl acetate and then from acetone afforded N- (2,3,4,6,6afi,7,8,9,9aa,9bfl-decahydro - 
181-1840C).
A solution of the above L-alanine conjugate (200mg) in dioxan (4ml) containing 0.1 M-HCl (0.5 ml) was heated on a boiling-water bath. After 8h of heating, the mixture was evaporated in vacuo to yield a residue. It was suspended in a small volume of water and then extracted with ethyl acetate. The extract was washed with water, dried over anhydrous Na2SO4 and then evaporated in vacuo to yield a gum (198mg), which was subjected to preparative t.l.c. (b) From the 5fl-dihydroxy acid (VI). The acid (1.041 g) was dissolved in a solution of N-hydroxysuccinimide (384mg) in anhydrous ethyl acetate (100ml) without heating. A solution of dicyclohexylcarbodi-imide (688mg) in anhydrous ethyl acetate (1 ml) was added to the solution, and the mixture was kept overnight at room temperature. Dicyclohexylurea, crystallized out in the mixture, was filtered off and the filtrate was evaporated in vacuo to afford a crystalline residue (1.416g), which was recrystallized from ethanol to yield 2,5-dioxopyrrolidin-1-yl (4R)-4-[3aa-hexahydro-5f-hydroxy-4a-(3 -hydroxypropyl)-7aj9-methylindan-/l3-yl]valerate (VII) as needles (911mg) The 5,6-dihydroxy ester (VII) (2.716g) in acetone (50ml) was treated with Jones reagent (8 nl) at room temperature for 2h. A small volume of 5% (w/v) NaHSO3 was added to the mixture to destroy the excess of CrO3. Then the mixture was neutralized with 5 % (w/v) NaHCO3 and concentrated in vacuo to about one-tenth of its original volume. The concentrate was diluted with water, acidified with dilute HCI and then extracted with ethyl acetate. The extract was washed with saturated NaCl and dried over anhydrous Na2SO4. Evaporation of the solvent in vacuo left a residue, which was chromatographed on silicic acid (120g). Elution with acetone/chloroform (from 1 :19, v/v, to 1:9, (VIII) , which, after treatment with acetone/light petroleum, formed an amorphous powder (2.08 g), m.p. 124.5-1260C, []g + 21.3 ± 1.20 (c 0.522 in ethanol) and i.r. max. at approx. 2600-3200 (OH of CO2H), 1818, 1788 and 1746 (N-hydroxysuccinimide ester) and 1706 (C=O and C=O of CO2H) cm-' (Found: C, 62.5; H, 7.5; N, 3.3; C22H3UN07 requires C, 62.7; H, 7.4; N, 3.3 %) .
A solution of the above half-ester (VIII) (825mg) in tetrahydrofuran (lOml) was added to a solution of L-alanine (174mg) and NaHCO3 (164mg) in water (lOml), with stirring and the mixture kept at room temperature for 20h. After concentration in vacuo to about one-tenth of its original volume, the con-centrate was diluted with water (2rml), acidified with dilute HCI to pH approx. 4 and then extracted with ether. Evaporation ofthe ether left a residue (274mg), which mainly consisted of a mnixture of the unaltered half-ester (VIII) and the oxodicarboxylic acid (II), as indicated by t.l.c. The aqueous layer was mixed with ether (approx. 1 ml), acidified with dilute HCI to cause incipient cloudiness and then kept overnight in a refrigerator. The prismatic crystals (343mg) that crystallized out in the aqueous layer were filtered, washed with water and then with ether and dried, Further recrystallization from acetone gave an analytical sample of the L-alanine conjugate (I-la), m.p. 160.5-161.50C and [&] 23 + 10.0± 1.40 (c0.35-1 in ethanol) (Found; C, 64.0; H, 8.5; N, 3.4; C±, H33NOd requires C, 63.8; H, 8.4; N, 3.5 Y.) . Identity with the above synthetic sample was determined by nixed m.p. and by comparison of the [a] , and the i.r.
spectrum.
L-Glutamtc acid conjugate (IlIb). The half-ester (VIII) (1g) in tetrahydrofuran (15ml) was treated with a solution of the disodium salt ofL-glutamic acid (349mg) in water (15nlm), exactly as described above in the preparation of compound (MIla). The resulting aqueous layer, after removal of ether-soluble materials (463mg), was acidified with dilute HCI to pH approx. 2 and thoroughly extracted with ethyl acetate. The extract was washed with saturated NaCl, dried over anhydrous Na2SO4 and then evaporated in vacuo to yield a colourless gum (567mg), which ran as a practically single spot (Rp 0.14) on t.l.c. When the gum was treated with 5 % (w/v) NaHCO3 to make a solution of the corresponding monosodium salt and approx. 1.6ml of the NaHCO3 solution had been consumed, it became a slurry containing needles. The slurry was diluted with acetone and filtered to collect the crystals (277mg). The mother liquor was evaporated in vacuo to dryness, treated with 5% (w/v) NaHCO3 (1 ml) and also yielded crystals (139mg).
The former crystals were recrystallized from water/ acetone to give the disodium salt ofN4 (CONH and COj2) cMn1 (Found: C, 55.8; H, 6.9; N, 3.1; Na, 7.1; C23H34NO8Na and C23H33NO8Na2 require C, 58.1; H, 7.2; N, 3.0; Na, 4.8%, and C, 55.5; H, 6.7 ; N, 2.8; Na, 9.3% respectively). The sample gave no satisfactory analytical data, probably owing to the presence of the corresponding monosodium salt, but it ran as one spot on t.l.c. All attempts to prepare the analytically pure corresponding monosodium or trisodium salt and to crystallize the corresponding free acid were unsuccessful.
The trtnethyl ester, prepared from the free acid with ethereal diazomethane, could not be induced to crystallize. The behaviour on t.l.c. and the i.r. and n.m.r. spectra were identical with those of the trimethyl ester of the metabolite (iIIb) obtained from growing cultures.
O(Acetyl-L-homoserine conjugate (Ilic). Exactly as described above in the preparation of compound (ITlb), the coupling reaction of the half-ster (VIII) (I g ) with the sodium salt of LAhomoserine (283mg) was carried out, and ether-soluble materials (202mg) and the corresponding L.homoserine conjugate (IX) (799rmg) were obtainod. The latter was contaminated with minute amounts of its y.lactone as indicated by the i.r. absorption at 1780cm-'. It was then suspended in water (approx. 5ml) and treated with I MNaOH (approx. 3.8 ml) to hydrolyse the lactone ring, yielding a clear solution of pH8. Evaporation of the water In vacuo at room temperature left a crystalline solid, which was recrystallized from water/acetone to afford the disodlum salt ofN-{(4R)4[44ac(2-carboxy. ethyl)-3acx-hexahydro-7a18-methyl.. (CONH and C02-) cm-' (Found: C, 56.7; H, 7.3; N, 3.1; Na, 10.4; C22H,3NO1Na2 requires C, 56.3; H 7.1; N, 3.0; Na, 9.8 %). The sample gave no satisfactory analytical values, but it ran as one spot (R* 0.12) on t.l.c.
Theabove disodium salt (500mg) was dissolved in a chilled solution (2.12ml) at 0°C consisting of 70% (w/v) HCIO4 (0.51 ml), water (0.04ml) and acetic acid (9.45ml), and acetic anhydride (0.48 ml) was then added dropwise with stirring. After 3.5h of the stirring at room temperature, the mixture was diluted with water (approx. 10ml) and treated with a drop of pyridine to destroy the acetic anhydride and to neutralize the HCI04. After concentration to about one-tenth ofits original volume with a stream ofN2 at room temperature, it was thoroughly extracted with ethyl acetate. The extract was washed with water, dried over anhydrous Na2SO4 and then evaporated in vacuo to yield a gum. After esterification with ethereal diazomethane, it was chromatographed on silica gel (21 g) that had been previously deactivated by the addition of water (5%, w/w). Elution with ether saturated with water gave O-acetyl-N{(4R)-4- difference in the i.r. spectrum between the synthetic sample and the isolated metabolite (IIId) was observed, although the latter was contaminated with minute quantities of foreign compounds, as indicated by t.l.c.
The dimethyl ester, prepared with ethereal diazomethane, could not be induced to crystallize. The behaviour on t.l.c. and the i.r. and n.m.r. spectra were identical with those of the dimethyl ester of the metabolite (IIId) obtained from growing cultures.
Discussion
The results of studies on incubation conditions show that, although not quantitatively, the inoculum of C. equi grown on the 5fi-dihydroxy acid (VI) surpasses that grown on the oxodicarboxylic acid (II) with regard to the accumulation of metabolites. We only used compound (VI) as carbon sources of a preculture medium in the hope that, compared with the latter inoculum, the former might have a lower compound-(II)-catabolizing activity and result in the slower degradation of compound (II) and its metabolites. No definite explanation for the biochemical role Vol. 160 of compound (VI) in the pre-lture tneditum can be offered at the presont time.
With regard to the origin of the a-amino-y-butyrolactone conjugate (X) isolated from the first run as a mixture with compound (IIIc), it isunknownwhether the conjugate (X) is either atruemetabolite oranartifact formed in the isolation process, especially in the extraction process of metabolites under acidic conditions. However, it may be the artifact, and the corresponding parent compound is probably the 0* acetylhomoserine conjugate (I11c) or i'ts deacylatated product, the homoserine conjugate (IX) (or both), although the latter was not isolated in the present work.
The results of the above chemical investigations show that the structure of all the isolated metabolites (I11a), (IIlb), (IIlc) and (IlId) consists of two parts, one part being the acid (II) used as the sole source of carbon and energy for the growth of C. equi and the other part being an amio acid or its derivative, which is probably a primary or secondary metabolite of this organism. They also indicate that the carboxyl group of the valeric acid side chain in the acid (H) molecule is linked by a peptide bond to the a-amino group of alanine, glutamic acid, O-acetylhomoserie or glutamine, although the configuration of these amino acids and their derivatives could not be established except for the alanine because of lack of material. Since the alanine was the L isomer, other amino acids and their derivatives probably have the L configuration, but definitive proof must await further investigations.
The occurrence of conjugation of a foreign compound to the body with a substance biosynthesized by the organism has been well known in animals (cf. Williams, 1963) . In higher plants, indol-3-ylacetic acid and other carboxylic acids are metabolized to their conugates with amino acids such as aspartic acid and glutamic acid (cf. Shantz, 1966) . In microorganisms, however, little is known about such synthetic reactions with amino acids, except for the report by Hutzinger & Kosuge (1968) , who demonstrated the conversion of indol-3-ylacetic acid into N'-(indol-3-ylacetyl)-L-lysine by Pseudomonas savastanoi.
The above results and information suggest that the metabolic reaction demonstrated in this present work is analogous to 'peptide conjugation' known in animals and higher plants. Support for this suggestion is provided by the evidence that the amino acid conjugates accumulated in the culture broth when the concentration of the acid (II) was 0.3 % and, if it was 0.1 % or less, the acid (II) was more rapidly degraded without the apparent accumulation of these conjugates: this means that the conjugates are probably formed by a mechanism similar to the detoxication of foreign compounds in animals (cf. Williams, 1963) . Hutzinger & Kosuge (1968) have also considered that, in the indol-3-ylacetic acid metabolism with Ps. savastanoi, N-(indol-3-ylacetyl)-L-lysine might be formed by the detoxication mechanism. From this point of view, the conjugates (IlIa), (TUb), (IIlc) and (MIId) are probably not the intermediate metabolites involved in the acid (II) degradation by C. equi. Thus the present reaction observed with C. equi could be considered as 'amino acid conjugation in bacteria'. The present results are also noteworthy from the viewpoint of comparative biochemistry: glutamine is a common reagent for conjugation in man and chimpanzee (cf. Williams, 1963) and also in C. equi, although it is not established yet whether glutamine itself participates in the formation of the glutamine conjugate (IHd) in C. equi, as discussed below. Further, it may be noted that in animnals a conjugation product is removed from the body, but in C. equi it is further metabolized by this organism, on continued incubation.
'Peptide conjugation' in animal tissues proceeds by the following two mechanisms (cf. Williams, 1963) : (1) involves the formation of CoA derivatives of foreign carboxylic acid; (2) an attack by a nucleophilic agent such as glycine on the resulting acyl-CoA derivatives. It is therefore conceivable that the Lalanine and glutamic acid conjugates, compounds (Illa) and (IITb), would be formed by the respective attack by L-alanine and glutamic acid on (4R)-4-[4a-(2-carboxyethyl)-3aa-hexahydro-7a,8-methyl-5-oxoindan-lfl-yl]valeryl-CoA. However, since amino acids could be acylated with both indol-3-ylacetylCoA and indol-3-ylacetyl-AMP (cf. Shantz, 1966) , the possibility that an activated form of the acid (II) comprises both the above CoA derivative and the corresponding hexahydroindanylvaleryl-AMP cannot be excluded. Further, there is also another possibility that a glutamine synthetase-type reaction in bacteria (cf. Stadtman & Ginsburg, 1974 ) might participate in this bacterial conjugation. The O-acetylhomoserine and glutamine conjugates, compounds (IlIc) and (IIId), are probably formed by either the respective direct conjugation of the acid (II) with O-acetylhomoserine and glutamine or by the 0-acetylation of the homoserine conjugate (IX) and the amidation of the glutamic acid conjugate (IlIb) (or both).
The amino acid conjugates isolated in this present work were not our expected metabolites of the acid (II), which would give an insight into the mechanism of further degradation of this acid. However, we have also found that C. equi can degrade the acid (II) to (4R)-4-[2a-(2 -carboxyethyl) -3f1-(3 -carboxypropionyl)-2fi-methylcyclopent-1fi-yl]valeric acid (cf. Hayakawa, 1973, pp. 178-180) and 5-methyl-4-oxooctane-1,8-dioic acid (S. Hayakawa & T. Fujiwara, unpublished work) .
